Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MARK1 anticorps (C-Term)

MARK1 Reactivité: Humain, Souris WB, EIA Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN359299
  • Antigène Voir toutes MARK1 Anticorps
    MARK1 (MAP/microtubule Affinity-Regulating Kinase 1 (MARK1))
    Épitope
    • 8
    • 8
    • 8
    • 8
    • 7
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    C-Term
    Reactivité
    • 58
    • 36
    • 12
    • 5
    • 5
    • 2
    • 2
    • 2
    • 2
    • 1
    Humain, Souris
    Hôte
    • 58
    • 1
    Lapin
    Clonalité
    • 59
    Polyclonal
    Conjugué
    • 27
    • 6
    • 5
    • 5
    • 5
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp MARK1 est non-conjugé
    Application
    • 45
    • 39
    • 28
    • 11
    • 8
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Enzyme Immunoassay (EIA)
    Specificité
    This antibody reacts to MARK1.
    Purification
    Protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
    Immunogène
    This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the C-terminal region of human MARK1.
    Isotype
    Ig Fraction
    Top Product
    Discover our top product MARK1 Anticorps primaire
  • Indications d'application
    ELISA: 1/1,000. Western Blot: 1/250 - 1/500.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.25 mg/mL
    Buffer
    PBS with 0.09 % (W/V) sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
  • Antigène
    MARK1 (MAP/microtubule Affinity-Regulating Kinase 1 (MARK1))
    Autre désignation
    MARK1 (MARK1 Produits)
    Synonymes
    anticorps MGC80341, anticorps MARK1, anticorps AW491150, anticorps B930025N23Rik, anticorps Emk3, anticorps Par-1c, anticorps mKIAA1477, anticorps mPar-1c, anticorps MARK, anticorps Par1c, anticorps MAP/microtubule affinity-regulating kinase 1 S homeolog, anticorps microtubule affinity regulating kinase 1, anticorps MAP/microtubule affinity-regulating kinase 1, anticorps MAP/microtubule affinity regulating kinase 1, anticorps mark1.S, anticorps MARK1, anticorps mark1, anticorps Mark1
    Sujet
    MARK is a family of kinases that is known for its involvement in establishing cell polarity and in phosphorylating tau protein during Alzheimer neurodegeneration. Expression of MARK causes the phosphorylation of MAPs at their KXGS motifs, thereby detaching MAPs from the microtubules and thus facilitating the transport of particles. This occurs without impairing the intrinsic activity of motors because the velocity during active movement remains unchanged. In primary retinal ganglion cells, transfection with tau leads to the inhibition of axonal transport of mitochondria, APP vesicles, and other cell components which leads to starvation of axons and vulnerability against stress. This transport inhibition can be rescued by phosphorylating tau with MARKSynonyms: MAP/Microtubule Affinity-Regulating Kinase 1, MARK, Serine/threonine-protein kinase MARK1
    ID gène
    4139
    NCBI Accession
    NP_061120
    UniProt
    Q9P0L2
    Pathways
    SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2
Vous êtes ici:
Support technique